Delivery Order #SPE2DP26F7273

Delivery Order for Prednisone Tablets under Long-Term Pharmaceutical Supply Contract

This award represents a delivery order contract for the procurement of prednisone tablets, issued under a broader definitive pharmaceutical supply contract. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distributor specializing in supplying essential medications to federal health agencies. This delivery order supports ongoing public health initiatives by ensuring the availability of a critical corticosteroid medication used in various medical treatments. The order focuses on supplying prednisone tablets during a short-term period in mid-2026 and is part of an established indefinite delivery vehicle contract designed to provide sustained and reliable pharmaceutical supplies. The award was consistent with the strategic procurement approach of the parent multi-year contract, indicating it was not a sole-source award. This contract helps maintain continuity of care and supports federal health agency efforts within a long-term healthcare provisioning framework. The parent award, a definitive pharmaceutical supply contract starting in 2025 and continuing through 2038, covers a broad portfolio of medications including injectable solutions and oral tablets, demonstrating comprehensive pharmaceutical coverage.

Description

8512233290!PREDNISONE TABLETS

View original record